312 related articles for article (PubMed ID: 30628737)
1. Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model.
Tahmasebi F; Pasbakhsh P; Mortezaee K; Madadi S; Barati S; Kashani IR
J Cell Biochem; 2019 Jun; 120(6):10576-10586. PubMed ID: 30628737
[TBL] [Abstract][Full Text] [Related]
2. Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945.
Beckmann N; Giorgetti E; Neuhaus A; Zurbruegg S; Accart N; Smith P; Perdoux J; Perrot L; Nash M; Desrayaud S; Wipfli P; Frieauff W; Shimshek DR
Acta Neuropathol Commun; 2018 Feb; 6(1):9. PubMed ID: 29448957
[TBL] [Abstract][Full Text] [Related]
3. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
4. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
Tanaka T; Murakami K; Bando Y; Yoshida S
J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte ablation induced by La-aminoadipate (L-AAA) potentiates remyelination in a cuprizone demyelinating mouse model.
Madadi S; Pasbakhsh P; Tahmasebi F; Mortezaee K; Khanehzad M; Boroujeni FB; Noorzehi G; Kashani IR
Metab Brain Dis; 2019 Apr; 34(2):593-603. PubMed ID: 30652255
[TBL] [Abstract][Full Text] [Related]
6. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.
Nomura T; Bando Y; You H; Tanaka T; Yoshida S
Neurochem Res; 2017 Dec; 42(12):3525-3536. PubMed ID: 28929408
[TBL] [Abstract][Full Text] [Related]
7. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Steelman AJ; Thompson JP; Li J
Neurosci Res; 2012 Jan; 72(1):32-42. PubMed ID: 22015947
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
[TBL] [Abstract][Full Text] [Related]
9. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in brain during cuprizone-induced demyelination and remyelination.
Morell P; Barrett CV; Mason JL; Toews AD; Hostettler JD; Knapp GW; Matsushima GK
Mol Cell Neurosci; 1998 Nov; 12(4-5):220-7. PubMed ID: 9828087
[TBL] [Abstract][Full Text] [Related]
11. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination.
Wu Y; Dong L; Huang Q; Sun L; Liao Y; Tang Y; Wu Y
Life Sci; 2019 Sep; 232():116501. PubMed ID: 31163175
[TBL] [Abstract][Full Text] [Related]
12. Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo.
Liu Y; Given KS; Dickson EL; Owens GP; Macklin WB; Bennett JL
Exp Neurol; 2019 Aug; 318():32-41. PubMed ID: 31029597
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell mediated effects on microglial phenotype in cuprizone-induced demyelination model.
Barati S; Ragerdi Kashani I; Moradi F; Tahmasebi F; Mehrabi S; Barati M; Joghataei MT
J Cell Biochem; 2019 Aug; 120(8):13952-13964. PubMed ID: 30963634
[TBL] [Abstract][Full Text] [Related]
14. The Spatial and Temporal Characters of Demyelination and Remyelination in the Cuprizone Animal Model.
Zhang Y; Cai L; Fan K; Fan B; Li N; Gao W; Yang X; Ma J
Anat Rec (Hoboken); 2019 Nov; 302(11):2020-2029. PubMed ID: 31251832
[TBL] [Abstract][Full Text] [Related]
15. Partial reduction of microglia does not affect tau pathology in aged mice.
Bennett RE; Bryant A; Hu M; Robbins AB; Hopp SC; Hyman BT
J Neuroinflammation; 2018 Nov; 15(1):311. PubMed ID: 30413160
[TBL] [Abstract][Full Text] [Related]
16. Regional differences between grey and white matter in cuprizone induced demyelination.
Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation.
Petković F; Campbell IL; Gonzalez B; Castellano B
Glia; 2016 Dec; 64(12):2104-2119. PubMed ID: 27535761
[TBL] [Abstract][Full Text] [Related]
18. Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model.
Aryanpour R; Pasbakhsh P; Zibara K; Namjoo Z; Beigi Boroujeni F; Shahbeigi S; Kashani IR; Beyer C; Zendehdel A
Int Immunopharmacol; 2017 Oct; 51():131-139. PubMed ID: 28830026
[TBL] [Abstract][Full Text] [Related]
19. Quantitative temporal changes in DTI values coupled with histological properties in cuprizone-induced demyelination and remyelination.
Yano R; Hata J; Abe Y; Seki F; Yoshida K; Komaki Y; Okano H; Tanaka KF
Neurochem Int; 2018 Oct; 119():151-158. PubMed ID: 29030079
[TBL] [Abstract][Full Text] [Related]
20. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.
El-Etr M; Rame M; Boucher C; Ghoumari AM; Kumar N; Liere P; Pianos A; Schumacher M; Sitruk-Ware R
Glia; 2015 Jan; 63(1):104-17. PubMed ID: 25092805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
